Antimicrobials Reporter: I1, Lin YH.. Introduction Patients in the ICU are often infected with...
-
date post
21-Dec-2015 -
Category
Documents
-
view
217 -
download
0
Transcript of Antimicrobials Reporter: I1, Lin YH.. Introduction Patients in the ICU are often infected with...
Introduction
Patients in the ICU are often infected with multiresistant organisms.Frequently exposed to broad-spectrum antibiotics
and invasive proceduresJudicious used of empiric antimicrobial therapy
is needed to minimize emergence of resistant organisms.Choice of antibiotic: suspected source of
infection, severity of the illness, local (hospital or ICU) microbiologic flora
Chapter OutlineChapter Outline◇◇ Learning objectives◇◇ Antibacterial Antibiotics◇◇ Antifungal Drugs◇◇ Antiviral Drugs◇◇ Summary◇◇ Review Questions
Learning Objectives
Recognize the different classes of antimicrobials and their mechanisms of action.
Identify the spectrum of coverage for specific antimicrobials.
Describe possible adverse effects and drug interactions caused by antimicrobials.
Select appropriate antimicrobials for various pathogens.
Chapter OutlineChapter Outline◇◇ Learning objectives◇◇ Antibacterial Antibiotics • Mechanisms of action and resistance • Spectrum of coverage • Pharmacology and adverse effects
◇◇ Antifungal Drugs◇◇ Antiviral Drugs◇◇ Summary◇◇ Review Questions
Pharmacology
Basctericidal / bacteriostatic
Mode of action: concentration-dependent / time-dependent killing effect
Minimal inhibitory concentration (MIC)
Postantibiotic effect (PAE)
Syngery / Indifference / Antogonism
GRAM-POSITIVE COCCI
Micrococcaceae familyM. luteus, M. roseus, and M. varians.
Micrococcaceae familyaureus: S. aureus non-aureus: S. epidermis
α-hemolysis: S. pyogenesβ-hemolysis: S. agalactiaeγ-hemolysis: Enterococcus / non-EnterococcusS. pneumoniae
GRAM-POSITIVE RODS
Aerobic: Endospore-forming: Bacillus
Regular, non-endospore-forming: Listeria
Irregular, non-endospore-forming: Corynebacterium
Anaerobic:
Endospore-forming: clostridium
Non-endospore-forming: Actinomycetes
GRAM-NEGATIVE
Aerobic cocci: Neisseria-- N. gonorrhoeae, N. meningitidis; Moraxella
Anaerobic cocci: Vellionella
Rods: (1) Enterobacteriaceae: Escherichia coli, Shigella,
Salmonella, Klebsiella, Enterobacter, Proteus… (2) Pleomorphic: Haemophilus, Legionella, Pasteurella,
Brucella (3) Miscellaneous: Vibrio, Campylobacter, Helicobacter (4) Nonfermenters: Pseudomonas, Acinebacter,
Flavobacterium
β-Lactams
Binding to penicillin-binding-protein (PBP)
inner cell membrane
endogeneous bacterial autolysis
Activity depend on:
(1) PBP type
(2) degree of affinity to a particular PBP
β-Lactams
Resistance:
(1)β-Lactamase enzyme: • nosocomial G (-) organisms: encoded on bacterial
chromosomes, plasmid mediated, or carried on transposons
•G(+): either inducible or constitutive and are ofter plasmid mediated
(2) Change permeability of outer membrane (3) Altering their PBP
β-Lactams
Penicillin groups: penicillin ring
Cephalosporin groups: cephalosporin ring
Monobactams: Aztreonam
Carbapenems:
(1) Imipenem-Cilastatin (Tienam)
(2) meropenem (Mepem)
β-Lactams : Penicillins
Penicillin G-like drugs: Penicillin G/ Penicillin V
Penicillinase-resistant penicillins: Dicloxacillin / Oxacillin / Methicillin / Nafcillin
Ampicillin-like drugs (Amino-PCNs) Ampicillin / Ampicillin + sulbactam (Unasyn)
Amoxicillin / Amoxicillin + clavulanic acid (Augmentin)
Broad-spectrum (antipseudomonal) penicillins: Ticarcillin/ Ticarcillin + Clavulanic Acid ( Timentin )
Piperacillin / Piperacillin + tazobactam (Tazocin )
β-Lactams : PCNs
Fallen out as 1st line empiric therapyDrug of choice for treatment of susceptible pathogensMost excreted rapidly by kidney (except: Nafcillin)Hypersensitivity most common side effectImmunogenicity
Penicillin: a. GPC: Streptococci, Treotococcus pneumoniae,
Enterococci b. Anaerobics: except Bacteroides fragilis c. Treptonema pallidum (syphilis)
Ampicillin / ampicillin-like drugs : GNB Hydrolyzed by many β-Lactamase Unasyn / Augmentin
a) Ampicillin: ‧ GPC: Liesteria monocytogenes & many Entecoccus spp. ‧ Community-acquired Enterobacteriaceae and Neiserria spp.
b) Amoxicillin: analog, superior oral bioavailability
New generation of penicillins: (1) β-lactam + β-lactamase inhibitor: a) Unasyn: Community acquired soft-tissue infection, intra-
abdomen or pelvic infection, polymicrobial RI. b) Augmentin: UTI, otitis media, sinusitis, bite wounds. (empiric coverage against β-lactamase-producing staphylococci, H.
influenzae, Neisseria gonorrhoeae, Moraxella catarrhalis, Bacteroides, and Klebsiella spp.)
(2) Antipseudomonal penicillins: GP + GN a) Timentin & Tazocin: polymicrobial soft-tissue infection
intra-abdomen or pelvic infection, LRI. b) Timentin Stenotrophomonas maltophilia; Tazocin p. aeruginosa.
First-generation Second-generation Third-generation Fourth-generation Cefadroxil Cefazolin (Veterin) Cephalexin (Ceflexin/ Keflex) Cephalothin Cephapirin Cephradine
Cefaclor (Keflor) Cefamandole Cefmetazole Cefonicid Cefotetan Cefoxitin Cefprozil Cefuroxime (Zinacef) Loracarbef
Cefixime (Cefspan) Cefoperazone (Cefobid) Cefotaxime Cefpodoxime Ceftazidime (Kefadin) Ceftibuten (Seftem) Ceftizoxime Ceftriaxone (Rocephin )
Latamoxcef (Shimarin)
Cefpirome(Cefrom ) Cefepime (Maxipime)
β-Lactams: Cephalosporins
2.5 generation- Cephamycinscefmetazole, ceftetan, cefoxitin
Similar mechanism to PCNsSide chain Coverage spectrum, pharmacokinetics, side
effectResistance: Enterobacter, Pseudomonas, Serratia,
Citrobacter spp. Not effect against enterococci or ORSAMost renally excreted Side effect:
a) Hypersensitivity
b) MTT side chain (N-methylthiotetrazole): ( 2nd- Cefamandole, Cefmetazole, Cefotetan)
caugulopathy (vit. K dependent CF) ; disulfiram-like reaction with ethanol flushing, sensation of warmth, giddiness, nausea, and occasionally tachycardia
β-Lactams: Cephalosporins
Against GPC
1st > 2nd > cephamycins > 3rd
Against GNB
1st < 2nd < cephamycins < 3rd
1st-generation cephalosporins
Activity: a) Against most GPC, including β-Lactamase
producine strains b) CAI-GNB, E. coli, Klebsiella spp. c) Typically resistance: B. fragilis, P. aeruginosa,
Enterobacter spp. d) No BBB penetration
Cefazolin (Veterin ): Longest T1/2 (1.7h) q8h; most effective to E. coli
2nd-generation cephalosporins
Expanded coverage to GNB
No BBB penetration
Cefuroxime (Zinacef):
a) very active against MSSA and Streptococcal species
b) β-Lactamase stable
3rd-generation cephalosporinsMore active in GNB but less active in GPC (especially S.
aureus)Drug of choice for GNB meningitisLead to superinfection with fungi. and enterococci (induce
production of β-Lactamase. Ex: p. aerugnosa, Citrobacter species…)
Anti-pseudomonal cephalosprins a) Ceftazidime (Kefadin) b) Cefoperazone (Cefobid)
Broad-spectrum cephalosporins: bac. Meningitis a) Ceftriaxone ( Rocephin= Sintrix) b) Cefotaxime
4th-generation cephalosporins
Anti-pseudomonas + Broad-spectrum 3rd
Less BBB peneration
Cefepime (Maxipime)
a) Enhanced stability against GNBβ-Lactamase ( Enterocobecter spp. Klebsiella…)
b) significant activity against GPC: S.aureus, pneumococci
c) Neutropenic fever: monotherapy
Penicillin groups: penicillin ring
Cephalosporin groups: cephalosporin ring
Monobactams: Aztreonam
Carbapenems:
(1) Imipenem-Cilastatin (Tienam)
(2) meropenem (Mepem)
β-Lactams : Monobactams
Aztreonam
a) only binds PBPs of aerobic G(-) bac.
(many strains of P.aeruginosa)
b) completely ineffective to all G(+) bac.
c) useful in allergic to PCNs
β-Lactams : Carbapenems
Tienam/ mepem Widest spectrum: 1) anaerobes, 2) most GPC (except Enterococcus faecium and ORSA)
3) most GNB (except: Stenotrophomonas maltophilia and Burkholderia cepacia )
Special stereochemical characteristics β-lactamase stable
Hypersensitivity similar with PCNsSeizure attack with predisposing factors (e.g., advanced age, renal insufficiency, Hx. of seizure)
Aminoglycosides
Amikacin (Amikin)/ Gentamicin/ Neomycin / NetromycinBactericidal for numerous G(+) & G(-) bacteriaNot active in
1) oxygen-poor environment 2) low PH ineffective to anaerobes and abscesses
Usually with β-Lactam antibiotics to GNBSynergy with PCNs to streptococcal, enterococcal
endocarditis
Interfering with protein synthesis during aerobic metabolism.
Good potensy: concentration-dependent killing effect and time-dependent PAE on G(+) and G(-) organismsPotency depend on
1) susceptibility to aminoglycoside-inactivating enzyme 2) permeability to cell wall
Aminoglycosides
AminoglycosidesExcreted rapidly by normally functioning kidney
TBW-dependent distribution: ↑dose in pregnancy, burns, ascites, septic shock ↓dose in renal insufficiency
Adverse effect: 1) Nephrotoxicity reversible but possible permanent renal failure monitor renal function during therapy
2) ototoxicity prolonged use (>14 days) , renal insufficiency,
concurrent use with other ototoxic agents.
★
★
★★
★
Fluoroquinolones:Ciprofloxacin (Ciproxin) Levofloxacin (Cravit ) / Nofloxacin ( Noxacin )
★
Fluoroquinolones
Ciprofloxacin (Ciproxin) / Levofloxacin (Cravit ) / Nofloxacin ( Noxacin )快速且完全自腸胃道吸收Synergic effect with some β-lactam antibioticsActive against:
1) Most GNB : Enterobacteriaceae, H. influenza, P. aeruginosa… 2) Many GPC目前為一對 P. aeruginosa有效的口服抗生素Resistance: mutations in DNA gyrase
Glycopeptides (Vancomycin )
Bactericidal against most G(+) bacteriaBacteriostatic to enterococci VRE↑Indication:
1) Serious infection with resistance to β-lactam-resistance G(+) bac.
2) Allergy with β-lactam antibiotics 3) Orally treatment of C. difficile colitis that lift-threatening 4) Endocarditis prophylaxis 5) prophylaxis in prosthetic implant 6) empiric use for suspected pneumococcal spp. meningitis
Histamine-related reaction: red men syndrome
Macrolides
Erythromycin/ Azithromycin / Clarithromycin (Klaricid) / Clindamycin
Bateriostatic
High tissue concentration but unreliable CSF penetration
Hepatic elimination
Resistance: alteration of ribosomal binding sites
Increase plasma level of theophylline, wafarin…
SulfonamideBuktar: Trimethoprim + SulfomethoxazolBacteriostatic antibiotics with a wide spectrum
against most G(+)& many G(-) organisms.Uncomplicated UTI, nocardiosis (土壤絲菌病) ,chancroid(軟下疳)
1) combine with pyrimethamine toxoplasmosis, 2) substitute for penicillin in prophylaxis of rheumatic fever 3) prophylaxis against susceptible meningococcal strains, in
ulcerative colitis (as sulfasalazine), in burns (as silver sulfadiazine or mafenide), in chloroquine-resistant Plasmodium falciparum infection, and in combination with trimethoprim
Nitromidazole (Metronidazole)
Active only against protozoa, such as Giardia lamblia(腸梨形蟲) , Entamoeba histolytica(痢疾阿米巴 ), and Trichomonas vaginalis(陰道滴蟲) , and strictly anaerobic bacteria (Bacteroides fragilis).
(Not active against aerobic or microaerophilic bacteria.)
Drug of choice in Clostridium difficile colitis.Drug of choice for bacterial vaginosis. It has also been
used successfully in Crohn's disease penetrates into the CSF in high concentrationsDisulfiram-like reaction may occur if alcohol is ingested